The Gaithersburg biotechnology company, Novavax, announced Monday morning data from phase 3 of its COVID-19 vaccine trials which were conducted in the United States and Mexico. Novavax found that the … Continue reading Novavax Says Its COVID-19 Vaccine Shows 90% Efficacy Rate